ELEVAI LABS INC.

Profile

Company Names

ELEVAI LABS INC.
REACTIVE MEDICAL LABS INC.

Addresses

120 NEWPORT CENTER DRIVE, STE. 250, NEWPORT BEACH, CA 92660

1120 NEWPORT CENTER DRIVE, STE. 250, NEWPORT BEACH, CA 92660

630 PENA DRIVE, SUITE 400, DAVIS, CA 95618

14781 POMERADO RD. #199, POWAY, CA 92064

Phone Numbers

1-866-794-4940
778-558-4949

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$5,656,995.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-09-08 
$249,996.00 
$549,990.00 
$299,994.00 
Equity 
5
2023-03-14 
$463,589.00 
$1,600,000.00 
$1,136,411.00 
Equity 
4
2023-03-03 
$750,000.00 
$1,500,000.00 
$750,000.00 
Equity 
3
2022-07-15 
$2,963,834.00 
$4,299,999.00 
$1,336,165.00 
Equity, Debt 
2
2021-08-24 
$1,090,577.00 
$2,000,000.00 
$909,423.00 
Equity 
1
2020-06-24 
$138,999.00 
$138,999.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HATEM 
 
ABOU-SAYED 
EXECUTIVE OFFICER, DIRECTOR
HATEM (TIM) 
 
ABOU-SAYED 
EXECUTIVE OFFICER, DIRECTOR
GRAYDON 
 
BENSLER 
EXECUTIVE OFFICER, DIRECTOR
BRENDA 
 
BUECHLER 
EXECUTIVE OFFICER
JULIE 
 
DALEY 
DIRECTOR
YI 
 
GUO 
DIRECTOR
CHRIS 
 
KRANEISS 
EXECUTIVE OFFICER
BRAEDEN 
 
LICHTI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CRYSTAL 
 
MUILENBURG 
DIRECTOR
JEFFREY 
 
PARRY 
DIRECTOR
JORDAN 
 
PLEWS 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-08 
D/A
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-14 
D/A
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-14 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-14 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-07-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-07-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-06-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
HAYWOOD SECURITIES (USA) INC.
NONE
NONE
UNIVEST SECURITIES, LLC